Literature DB >> 9278941

Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni.

L A Dent1, G H Munro, K P Piper, C J Sanderson, D A Finlay, R K Dempster, L P Bignold, D G Harkin, P Hagan.   

Abstract

Eosinophilia is a feature common to many invasive helminth infections and eosinophils are often considered to be effector cells in immunity to helminths. This study examined the possible influence of constitutive eosinophilia on the clearance of Schistosoma mansoni infections in mice. Eosinophils from interleukin-5 transgenic mice exhibit normal ultrastructure and function with regard to phagocytosis and killing of bacteria and responses to chemotactic stimuli. IL-5 transgenics and non-transgenic littermates were immunized once or four (hyperimmunization) times with irradiated cercariae of S. mansoni. Animals were challenged percutaneously with unirradiated cercariae one month after their last exposure to irradiated parasites. One month after challenge transgenic animals, whether unimmunized, vaccinated or hypervaccinated, carried significantly more liver-stage parasites than non-transgenic animals. These results suggest that although eosinophils from IL-5 transgenic mice are functional for a number of key parameters, large numbers of eosinophils and/or high levels of IL-5 may in some way impair clearance of S. mansoni. A re-evaluation of the roles of eosinophils and IL-5 in infections with this and other parasites may therefore be warranted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278941     DOI: 10.1046/j.1365-3024.1997.d01-210.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  15 in total

1.  Correlated evolution between host immunity and parasite life histories in primates and oxyurid parasites.

Authors:  Gabriele Sorci; Frode Skarstein; Serge Morand; Jean-Pierre Hugot
Journal:  Proc Biol Sci       Date:  2003-12-07       Impact factor: 5.349

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

3.  Trapping and immobilization of Nippostrongylus brasiliensis larvae at the site of inoculation in primary infections of interleukin-5 transgenic mice.

Authors:  C M Daly; G Mayrhofer; L A Dent
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Eosinophil and IgE responses of IL-5 transgenic mice experimentally infected with Nippostrongylus brasiliensis.

Authors:  J Y Chai; E H Shin; K Takatsu; N Matsumoto; S Kojima
Journal:  Korean J Parasitol       Date:  1999-06       Impact factor: 1.341

Review 5.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

Review 6.  Mucosal immunity against parasitic gastrointestinal nematodes.

Authors:  D N Onah; Y Nawa
Journal:  Korean J Parasitol       Date:  2000-12       Impact factor: 1.341

7.  Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice.

Authors:  Ann Marie Galioto; Jessica A Hess; Thomas J Nolan; Gerhard A Schad; James J Lee; David Abraham
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  FVB/N mice are highly resistant to primary infection with Nippostrongylus brasiliensis.

Authors:  M L Knott; S P Hogan; H Wang; K I Matthaei; L A Dent
Journal:  Parasitology       Date:  2009-01       Impact factor: 3.234

9.  Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis.

Authors:  Carine Bouffi; Andrey V Kartashov; Kaila L Schollaert; Xiaoting Chen; W Clark Bacon; Matthew T Weirauch; Artem Barski; Patricia C Fulkerson
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

Review 10.  Eosinophils and helminth infection: protective or pathogenic?

Authors:  E Mitre; A D Klion
Journal:  Semin Immunopathol       Date:  2021-06-24       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.